Survival: Clinical Trials

2 trials for Survival, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Survival: new trials by email Literature Review of Survival trials Research Report on Survival

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
Astragalus Polysaccharides 500 mg - Cancer-related Fatigue, Survival
Phase 2CompletedPhytoHealth Corporation482019-02-192025-06-04
Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients
metronomic XELOX, Classic XELOX, Blood samples for pharmacological studies - Clinical Response, Toxicity
Phase 2CompletedNational Cancer Institute, Egypt702016-01-012020-06-11

Narrower conditions

Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Neoplasms (1)

Broader conditions

Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Colonic Diseases (1)  ·  Esophageal Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Rectal Diseases (1)

Interventions

Blood Specimen Collection (1)  ·  Capecitabine (1)  ·  Oxaliplatin (1)

Sponsors

National Cancer Institute, Egypt (1)  ·  PhytoHealth Corporation (1)

Countries

Taiwan (1)

Top investigators

Wen-Chien WC Huang, MD, PhD (1)